Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.

Main|Search|PHGKB

From CDC-Authored Genomics Publication Database

This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.

---

• Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.
  Feng Lisa B et al. Health affairs (Project Hope) 2018 May 37(5) 773-779
• The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
  Grosse Scott D et al. The Milbank quarterly 2016 94(2) 366-91
• Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
  Grosse Scott D et al. Healthcare (Basel, Switzerland) 2015 3(4) 1133-57
• Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
  Baker Mei W et al. Genet. Med. 2015 Feb 12.
• CFTR mutation analysis and haplotype associations in CF patients.
  Cordovado S K et al. Mol. Genet. Metab. 2012 Feb 105(2) 249-54
• Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.
  Earley Marie C et al. Clin. Chim. Acta 2011 Jul 15. 412(15-16) 1376-81
• Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.
  Korzeniewski Steven J et al. Pediatric pulmonology 2011 Feb 46(2) 125-30

Go to CDC-Authored Genomics Publication Database